33
/de/
AIzaSyB4mHJ5NPEv-XzF7P6NDYXjlkCWaeKw5bc
November 1, 2025
2135676
178559
2
Create a timeline
Public Timelines
For educational institutions For teachers For students Cabinet
For educational institutions For teachers For students Open cabinet
FAQ Das Premium bekommen
Create a timeline
Public timelines
FAQ
About & FeedbackVereinbarungPrivatheitFAQ
Support 24/7  
CabinetGet premium
Donate

27 März 2018 Jahr - FDA held a meeting of the Psychopharmacologic Drugs Advisory Committee to discuss the new drug application for lofexidine hydrochloride, submitted by US WorldMeds, LLC, for mitigation of symptoms associated with opioid withdrawal and facilitation of completion of opioid discontinuation treatment.

Zugefügt zum Band der Zeit:

Opioids and the FDA

ByAnastasia
13 Nov 2018
0
0
522

Datum:

27 März 2018 Jahr
Jetzt
~ 7 years and 7 months ago
About & FeedbackVereinbarungPrivatheitFAQ
Support 24/7  
CabinetGet premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL